13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 28 holding rows worth $183,931,000.
- Accession
- 0001831942-21-000002
- Filer
- CIK 1831942
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 28 entries on the cover page, a total value of $183,931,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $183,931,000 with VALUE read as thousands by filing date, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 481,094 | $15,939,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 852,871 | $12,546,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 423,708 | $12,203,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 532,000 | $9,049,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 298,839 | $8,926,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,274,261 | $8,805,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,336,275 | $8,646,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 760,025 | $8,535,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,486,107 | $8,530,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 125,000 | $7,689,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 330,315 | $7,346,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 467,368 | $7,188,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 347,500 | $7,006,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,854,278 | $6,638,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 356,431 | $6,245,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 3,150,000 | $6,111,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 178,565 | $5,727,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 97,143 | $4,502,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 133,503 | $4,360,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 467,796 | $4,322,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427401 | COMMON STOCK | 1,765,901 | $4,273,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 158,827 | $4,226,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 83,782 | $3,870,000 | thousands by filing date | |
| INVENTIVA SA | 46124U107 | ADS | 231,000 | $3,350,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 250,000 | $2,785,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 264,690 | $2,067,000 | thousands by filing date | |
| MILLENDO THERAPEUTICS INC | 60040X103 | COM | 925,000 | $1,980,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 100,000 | $1,067,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-21-000002 | this filing | 2021-02-16 | acceptance time not in the bulk data set |